Literature DB >> 15778114

Ethical issues in HIV.

Amaboo Dhai1, Ray Noble.   

Abstract

The number of people with HIV/AIDS continues to increase globally. Women, who represent the subgroup with the fastest rate of increase, are usually informed of their serostatus by the obstetrician/gynaecologist. As treatment of infected women raises a number of ethical issues, an understanding of the theoretical background for ethical decision making is requisite to ensure these problems are resolved within a morally appropriate framework. Vigorous debate has arisen from the tensions between the competing goals of HIV testing, third party disclosure, management of the critically ill HIV-infected woman, infertility management in the background of HIV/AIDS, and gender-based violence as cause or result of acquiring HIV infection. Women may be differently empowered economically, socially and culturally. What may be a satisfactory solution in the context of the USA and Europe may be far from ideal in that of the developing world.

Entities:  

Keywords:  Health Care and Public Health

Mesh:

Year:  2004        PMID: 15778114     DOI: 10.1016/j.bpobgyn.2004.10.001

Source DB:  PubMed          Journal:  Best Pract Res Clin Obstet Gynaecol        ISSN: 1521-6934            Impact factor:   5.237


  3 in total

1.  "If the patients decide not to tell what can we do?"- TB/HIV counsellors' dilemma on partner notification for HIV.

Authors:  Barnabas N Njozing; Kerstin E Edin; Miguel San Sebastián; Anna-Karin Hurtig
Journal:  BMC Int Health Hum Rights       Date:  2011-06-03

2.  A qualitative study of pregnancy-related anxiety among women in Tanzania.

Authors:  Melanie King Rosario; Shahirose Sadrudin Premji; Elias Charles Nyanza; Shelley Raffin Bouchal; David Este
Journal:  BMJ Open       Date:  2017-08-03       Impact factor: 2.692

3.  HIV recency testing: should results be disclosed to individuals tested?

Authors:  Quarraisha Abdool Karim; Ruth Macklin; Sofia Gruskin; Sara Klucking; Lejeune Lockett; Celia J Maxwell; Kenneth H Mayer; Edwin Sanders; Frederick Sawe
Journal:  J Int AIDS Soc       Date:  2020-08       Impact factor: 5.396

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.